Home > Insider Trading > Filing (0001189727-18-000012)

Filing Details

Accession Number:: 0001189727-18-000012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-21 18:25:42
Reporting Period:: 2018-06-21

Accepted Time:: 2018-06-21 18:25:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
883984	Icu Medical Inc	ICUI	Surgical & Medical Instruments & Apparatus (3841)	330022692

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189727	D Alison Burcar	951 Calle Amanecer San Clemente CA 92673	Vice President And Gen'l Mgr.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-06-21	13,219	$88.76	13,219	No	4	X	Direct
Common Stock	Acquisiton	2018-06-21	1,976	$58.79	15,195	No	4	X	Direct
Common Stock	Disposition	2018-06-21	3,320	$295.27	11,875	No	4	S	Direct
Common Stock	Disposition	2018-06-21	4,704	$296.34	7,171	No	4	S	Direct
Common Stock	Disposition	2018-06-21	5,502	$297.38	1,669	No	4	S	Direct
Common Stock	Disposition	2018-06-21	1,412	$298.24	257	No	4	S	Direct
Common Stock	Disposition	2018-06-21	257	$301.12	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	X	Direct
No	4	X	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-06-21	1,976	$0.00	1,976	$58.79
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-06-21	13,219	$0.00	13,219	$88.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-02-24	No	4	X	Direct
0		2025-02-11	No	4	X	Direct

Footnotes

The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
Transaction is the exercise of a derivative security; see Column 2.
Options exercisable one-third annually over the first three anniversaries of the grant date.